Xifeng Wang

This publication record appears to combine work from multiple distinct research areas, including neuroscience and cognitive function (e.g., PIEZO1 signaling, sepsis-related brain injury, postoperative cognitive decline), cancer biology and clinical oncology (e.g., chronic lymphocytic leukemia treatment trials, tumor biomarkers), inflammation and disease mechanisms (e.g., TRIM proteins, VCAM-1), and neuroimaging methodology. Because the topics and venues are so varied, prospective students should look closely at the specific papers and collaborators to understand which particular line of research this name is associated with, as the bibliographic data may represent contributions across several unrelated projects or possibly multiple researchers sharing the same name.

Publication output grew substantially from 2017 to around 2021-2023 and has remained at a relatively high and fairly steady level (10-16 papers per year) through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026